Expression of stem cell factor (SCF) and SCF receptor (c-kit) in synovial membrane in arthritis: Correlation with synovial mast cell hyperplasia and inflammation

Journal of Rheumatology

Volumn 25, Issue 12, 1998, Pages 2304-2314

  Čeponis, Arnoldas ^a,b   Konttinen, Yrjö T ^b,c   Takagi, Michiaki ^d   Xu, Jing Wen ^b   Sorsa, Timo ^e   Matucci Cerinic, Marco ^f   Santavirta, Seppo ^c   Bankl, Hans Christian ^g   Valent, Peter ^g  

^a ORTON Invalid Foundation   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITY OF HELSINKI   (Finland)

^f UNIVERSITY OF FLORENCE   (Italy)

^g UNIVERSITY OF VIENNA   (Austria)

Author keywords

c kit; Mast cells; Rheumatoid arthritis; Stem cell factor; Synovial membrane

Indexed keywords

STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR;

ADULT; ARTICLE; CELL PROLIFERATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOPATHOGENESIS; INFLAMMATORY INFILTRATE; MALE; MAST CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVIUM; TISSUE DISTRIBUTION;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS; CELL LINE; FEMALE; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KI-67 ANTIGEN; LUNG; MALE; MAST CELLS; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-KIT; STEM CELL FACTOR; SYNOVIAL MEMBRANE;

EID: 0031742005     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Galli SJ. New concepts about the must cell. N Engl J Med 1993;328:257-65.
2. Gordon JR, Burd PR, Galli SJ. Mast cells as a source of multifunctional cytokines. Immunol Today 1990;11:458-64.
3. Wasserman SI. The mast cell and synovial inflammation. Or, what's a nice cell like you doing in a joint like this? Arthritis Rheum 1984;27:841-4.
4. Woolley DE, Yoffe JR, Evanson JM. Mast cells and matrix degradation in the rheumatoid joint. In: Tschesche H, editor. Proteinases in inflammation and tumour invasion. Berlin and New York: Walter Gruyter;1986:61-76.
5. Mican JM, Metcalfe DD. Arthritis and mast cell activation. J Allergy Clin Immunol 1990;86:677-83.
6. Woolley DE. Mast cells in the rheumatoid lesion - ringleaders or innocent bystanders? Ann Rheum Dis 1995;54:533-4.
7. Arnason JA, Malone DJ. Role of mast cells in arthritis. In: Marone G, editor. Human basophils and mast cells: clinical aspects. Basel: Karger. Chem Immunol 1995;62:204-38.
8. Zenmyo M, Hiraoka K, Komiya S, Morimatsu M, Sasaguri Y. Histamine-stimulated production of matrix metalloproteinase 1 by human rheumatoid synovial fibroblasts is mediated by histamine H1-receptors. Virchows Arch 1995;427:437-44.
9. Qu Z, Huang XN, Ahmadi P, Andresevic J, Plank SR, Hart CE, Rosenbaum JT. Expression of basic fibroblast growth factor in synovial tissue from patients with rheumatoid arthritis and degenerative joint disease. Lab Invest 1995;73:339-46.
10. Dean G, Hoyland JA, Denton J, Donn RP, Freemont AJ. Mast cells in the synovium and synovial fluid in osteoarthritis. Br J Rheumatol 1993;32:671-5.
11. Crisp AJ, Chapman CM, Kirkham SE, Schiller AL, Krane SM. Articular mastocytosis in rheumatoid arthritis. Arthritis Rheum 1984;27:845-51.
12. Godfrey HP, Ilardi C, Engber W, Graziano FM. Quantitation of human synovial mast cells in rheumatoid arthritis and other rheumatic diseases. Arthritis Rheum 1984;27:852-6.
13. Malone DG, Wilder RL, Saavedra-Delgado AM, Metcalfe DD. Mast cell numbers in rheumatoid synovial tissues. Correlations with quantitative measures of lymphocytic infiltration and modulation by antiinflammatory therapy. Arthritis Rheum 1987;30:130-7.
14. Frewin DB, Cleland LG, Jonsson JR, Robertsson PW. Histamine levels in human synovial fluid. J Rheumatol 1986;13:13-4.
15. Lavery JP, Lisse JR. Preliminary study of the tryptase levels in the synovial fluid of patients with inflammatory arthritis. Ann Allergy 1994;72:425-7.
16. Tetlow LC, Woolley DE. Distribution, activation and tryptase/ chymase phenotype of mast cells in the rheumatoid lesion. Ann Rheum Dis 1995;54:549-55.
17. Malone DG, Irani A-M, Schwartz LB, Barret KE, Metcalfe DD. Mast cell numbers and histamine levels in synovial fluids from patients with diverse arthritides. Arthritis Rheum 1986;29:956-63.
18. Gruber B, Poznansky M, Boss E, Partin J, Gorevic P, Kaplan AP. Characterization and functional studies of rheumatoid synovial mast cells. Activation by secretagogues, anti-IgE, and a histamine-releasing lymphokine. Arthritis Rheum 1986;29:944-55.
19. Valent P, Bettelheim P. Cell surface structures on human basophils and mast cells. Biochemical and functional characterization. Adv Immunol 1992;452:333-423.
20. De Paulis A, Marinò I, Ciccarelli A. et al. Human synovial mast cells. I. Ultrastructural in situ and in vivo immunologic characterization. Arthritis Rheum 1996;39:1222-33.
21. Valent P. The riddle of the mast cell: kit(CD117)-ligand as the missing link? Immunol Today 1994;15:111-4.
22. Galli SJ. New insights into "the riddle of the mast cells": microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab Invest 1990;62:5-33.
23. Valent P, Besemer J, Sillaber C, et al. Failure to detect IL-3-binding sites on human mast cells. J Immunol 1990;145:3432-7.
24. Valent P, Spanglöchl E, Sperr WR, et al. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long term culture. Blood 1992;80:2237-45.
25. Galli SJ, Zsebo KM, Geissler EN. The kit ligand, stem cell factor. Adv Immunol 1994;55:1-96.
26. Weiss RR, Whitaker-Menezes D, Longley J, Bender J, Murphy GF. Human dermal endothelial cells express membrane-associated mast cell growth factor. J Invest Dermatol 1995;1:101-6.
27. Galli SF, Tsai M, Wershil BK. The c-kit receptor, stem cell factor and mast cells. What each is teaching us about the others. Am J Pathol 1993;142:965-74.
28. Nilsson G, Butterfield JH, Nilsson K, Siegbahn A. Stem cell factor is chemotactic for human mast cells. J Immunol 1994;153:3718-23.
29. Kinashi T, Springer TA. Steel factor and c-kit regulate cell-matrix adhesion. Blood 1994;83:1033-8.
30. Bishoff SC, Schwengberg S, Wordelmann, Weismann A, Raab R, Manns MP. Effect of c-kit ligand, stem cell factor, on mediator release by human intestinal mast cells isolated from patients with inflammatory bowel disease and controls. Gut 1996;38:104-14.
31. Taylor AM, Galli SJ, Coleman JW. Stem-cell factor, the kit ligand. induces direct degranulation of rat peritoneal mast cells in vitro and in vivo: dependence of the in vitro effects on period of culture and comparisons of stem-cell factor with other mast cell-activating agents. Immunology 1995;86:427-33.
32. Iemura A, Tsai M, Ando A, Wershil BK, Galli SJ. The c-kit ligand, stem cell factor, promotes mast cell survival by supressing apoptosis. Am J Pathol 1994;144:321-8.
33. Kiener H, Baghestanian M, Dominkus M, et al. Expression of the C5a receptor (CD88) on synovial mast cells in patients with rheumatoid arthritis. Arthritis Rheum 1998;41:233-45.
34. Brown DC, Gatter KC. Monoclonal antibody Ki-67: its use in histopathology. Histopathology 1990;17:489-503.
35. Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis Rheum 1986;29:1039-49.
36. Arnett FC, Edworthy SM, Bloch DA. et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
37. Castelis MC, Friend DS, Bunnell CA, et al. The presence of membrane-bound stem cell factor on highly immature nonmetachromatic mast cells in the peripheral blood of a patient with aggressive systemic mastocytosis. J Allergy Clin Immunol 1986;98:831-40.
38. Hukkanen M, Grönblad M, Rees RG, et al. Regional distribution of mast cells and peptide-containing nerves in normal and adjuvant arthritic rat synovium. J Rheumatol 1991;43:7-19.
39. Schwartz LB. Mediators of human mast cells and human mast cell subsets. Ann Allerg 1987;58:226-35.
40. Konttinen YT, Hukkanen M, Segerberg M, et al. Relationship between neuropeptide immunoreactive nerves and inflammatory cells in adjuvant arthritic rats. Scand J Rheumatol 1992;21:55-9.
41. Lassus J, Ranki A. Simultaneously detected aberrant p53 tumor suppressor protein and HPV-DNA localize mostly in separate keratinocytes in anogenital and common warts. Exp Dermatol 1996;5:72-8.
42. Willheim M, Agis H, Sperr WR, et al. Purification of human basophils and mast cells by multistep separation technique and mAb to CDw17 and CD117/c-kit. J Immunol Methods 1995;182:115-29.
43. Bankl HC, Radaszkiewicz T, Klappacher G, et al. Increase and redistribution of cardiac mast cells in auricular thrombosis. Possible role of kit ligand. Circulation 1995;91:275-83.
44. Baghestanian M, Agis H, Bevec D, et al. Stem cell factor-induced downregulation of c-kit in human lung mast cells and HMC-1 mast cells. Exp Hematol 1996;24:1377-86.
45. Gattei V, Aldinucci D, Quinn JMW, et al. Human osteoclasts and preosteoclast cells (FLG 29.1) express functional c-kit receptors and interact with osteoblast and stromal cells via membrane-bound stem cell factor. Cell Growth Differ 1996;7:753-63.
46. Seibold JR, Giorno RC, Claman HN. Dermal mast cell degranulation in systemic sclerosis. Arthritis Rheum 1990;33: 1702-9.
47. Bromley M, Fisher W, Woolley D. Mast cells at the sites of cartilage erosion in the rheumatoid joint. Ann Rheum Dis 1984;43:76-9.
48. Valent P, Ashman LK, Hinterberg W, et al. Mast cell typing: demonstration of a distinct hematopoietic cell type and evidence for immunophenotypic relationship to mononuclear phagocytes. Blood 1989;73:1778-85.
49. Huang EJ, Nocka KH, Buck J, Besmer P. Differential expression and processing of two cell associated forms of the kit-ligand: KL-1 and KL-2. Mol Biol Cell 1992;3:349-62.
50. Longley BJ Jr, Morganroth GS, Tyrrell L, et al. Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. N Engl J Med 1993;328:1302-7.
51. Firestein GS, Xu W-D, Townsend K, et al. Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophage colony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitis. J Exp Med 1988;168:1573-86.